VANGUARD GROUP INC - PLUS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PLUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$316,956
-8.5%
1,092,9530.0%0.00%
Q4 2022$346,466
-28.7%
1,092,953
+0.0%
0.00%
Q3 2022$486,000
+5.2%
1,092,568
+27.7%
0.00%
Q2 2022$462,000
-46.0%
855,2640.0%0.00%
Q1 2022$855,000
+14.2%
855,264
+20.0%
0.00%
Q4 2021$749,000
-45.0%
712,8470.0%0.00%
Q3 2021$1,361,000
-25.4%
712,8470.0%0.00%
Q2 2021$1,825,000
+886.5%
712,847
+824.7%
0.00%
Q1 2021$185,000
+330.2%
77,086
+263.0%
0.00%
Q4 2020$43,000
+10.3%
21,236
+39.0%
0.00%
Q3 2020$39,000
+21.9%
15,2810.0%0.00%
Q2 2020$32,00015,2810.00%
Other shareholders
PLUS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 3$00.00%
VICTORY CAPITAL MANAGEMENT INC 1,294$2,0000.00%
Darwin Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 4$00.00%
Wealthcare Advisory Partners LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 26$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 20$00.00%
ACADIAN ASSET MANAGEMENT LLC 9,003$17,0000.00%
View complete list of PLUS THERAPEUTICS INC shareholders